Approval · Notice of Compliance 33461 · 2024
MINT-ACARBOSE: Notice of Compliance 33461
Issued June 18, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33461
- Date
- June 18, 2024
- Company
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
- Canadian reference product
- GLUCOBAY (Bayer Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MINT-ACARBOSE | 02493780 | Dormant |
| MINT-ACARBOSE | 02493799 | Dormant |